Cassava Sciences, Inc. Warrant
NASDAQ Global MarketTotal Valuation
Cassava Sciences, Inc. Warrant carries a market capitalization of 1.45M, placing it among publicly traded companies globally. Its enterprise value stands at -82.68M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.45M |
| Enterprise Value | -82.68M |
Share Statistics
Cassava Sciences, Inc. Warrant currently has 48.31M shares outstanding.
| Shares Outstanding | 48.31M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Financial Position
Cassava Sciences, Inc. Warrant maintains a current ratio of 2.08, meaning it holds 2.1x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 2.08 |
| Quick Ratio | 2.06 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | -55.78 |
| Return on Assets (ROA) | -35.34 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
Cassava Sciences, Inc. Warrant's stock has declined approximately -99.05363% over the past 52 weeks. The 50-day moving average sits at 3.49, while the 200-day moving average is 4.93.
| Beta (5Y) | N/A |
| 52-Week Price Change | -99.05363% |
| 50-Day Moving Average | 3.49 |
| 200-Day Moving Average | 4.93 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -45.72M, while operating income came in at -46.71M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -46.71M |
| Pretax Income | -42.28M |
| Net Income | -42.28M |
| EBITDA | -45.72M |
| EBIT | -46.71M |
| Earnings Per Share (EPS) | N/A |
Balance Sheet
Total book value stands at 63.61M, with working capital of 43.57M providing operational flexibility.
| Cash & Cash Equivalents | 82.68M |
| Total Debt | N/A |
| Net Debt | -82.68M |
| Equity (Book Value) | 63.61M |
| Book Value Per Share | 1.32 |
| Working Capital | 43.57M |
Cash Flow
Cassava Sciences, Inc. Warrant produced -28.70M in operating cash flow over the past twelve months.
| Operating Cash Flow | -28.70M |
| Capital Expenditures | -581,000.00 |
| Free Cash Flow | -29.28M |
| FCF Per Share | N/A |
Scores
Cassava Sciences, Inc. Warrant posts an Altman Z-Score of -7.92, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -7.92 |